GB202211142D0 - Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof - Google Patents

Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof

Info

Publication number
GB202211142D0
GB202211142D0 GBGB2211142.1A GB202211142A GB202211142D0 GB 202211142 D0 GB202211142 D0 GB 202211142D0 GB 202211142 A GB202211142 A GB 202211142A GB 202211142 D0 GB202211142 D0 GB 202211142D0
Authority
GB
United Kingdom
Prior art keywords
fruquintinib
polymorphs
solvates
crystals
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2211142.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macfarlan Smith Ltd
Original Assignee
Macfarlan Smith Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macfarlan Smith Ltd filed Critical Macfarlan Smith Ltd
Priority to GBGB2211142.1A priority Critical patent/GB202211142D0/en
Publication of GB202211142D0 publication Critical patent/GB202211142D0/en
Priority to PCT/IB2023/057714 priority patent/WO2024023796A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2211142.1A 2022-07-29 2022-07-29 Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof Ceased GB202211142D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2211142.1A GB202211142D0 (en) 2022-07-29 2022-07-29 Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof
PCT/IB2023/057714 WO2024023796A1 (en) 2022-07-29 2023-07-28 Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2211142.1A GB202211142D0 (en) 2022-07-29 2022-07-29 Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof

Publications (1)

Publication Number Publication Date
GB202211142D0 true GB202211142D0 (en) 2022-09-14

Family

ID=84540566

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2211142.1A Ceased GB202211142D0 (en) 2022-07-29 2022-07-29 Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof

Country Status (2)

Country Link
GB (1) GB202211142D0 (en)
WO (1) WO2024023796A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105461702A (en) * 2014-09-10 2016-04-06 和记黄埔医药（上海）有限公司 6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide crystal form
CN105777721A (en) * 2014-12-22 2016-07-20 上海宣创生物科技有限公司 Quinazoline derivative A crystal form and preparation method and application thereof
CN105777722A (en) * 2014-12-22 2016-07-20 上海宣创生物科技有限公司 Quinazoline derivative C crystal form, preparation method and application thereof
CN105777723A (en) * 2014-12-22 2016-07-20 上海宣创生物科技有限公司 Quinazoline derivative B crystal form, preparation method and application thereof
US11236077B2 (en) * 2018-03-30 2022-02-01 Hangzhou Solipharma Co., Ltd. Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof
CN112724110B (en) * 2021-01-13 2021-10-26 广州安岩仁医药科技有限公司 Synthesis method of VEGFR inhibitor furoquintinib and benzofuran intermediate thereof

Also Published As

Publication number Publication date
WO2024023796A1 (en) 2024-02-01

Similar Documents

Publication Publication Date Title
IL285782A (en) Compounds, compositions, and methods for the treatment of disease
EP3634970A4 (en) Novel process for preparation of empagliflozin or its co-crystals, solvates and their polymorphs thereof
ZA202101214B (en) Process and intermediates for the preparation of bilastine
EP3756757A4 (en) Method for preparation of supported carbon catalyst, and supported carbon catalyst and use thereof
IL291221A (en) Processes for the synthesis of valbenazine
IL290181A (en) Process for the preparation of fluensulfone
IL289904A (en) Process for the preparation of biphenylamines
IL290185A (en) Solid state forms of risdiplam and process for preparation thereof
PL3830073T3 (en) Process for the monotopic preparation of intermediate organo-iodinated compounds for the synthesis of ioversol
IL287632A (en) Process for the synthesis of cannabidiol and intermediates thereof
GB202211142D0 (en) Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof
WO2015111085A8 (en) Processes for the preparation of eltrombopag and pharmaceutically acceptable salts, solvates and intermediates thereof
GB202009917D0 (en) Process for the preparation of iopamidol
HUE058259T2 (en) Process for the preparation of lubiprostone and intermediates thereof
IL290169A (en) Process and intermediates for the preparation of pyroxasulfone
EP3843791A4 (en) Adeno-associated viral vectors for the treatment of best disease
PL3737685T3 (en) Process for the preparation of crisaborole and its intermediates
ZA202107053B (en) Novel process for the preparation of filgotinib and intermediates thereof
IL280606A (en) Process and intermediates for the preparation of certain nematicidal sulfonamides
EP3860967A4 (en) Preparation of 2,3,3,3-tetrafluoropropene and intermediates thereof
GB202213849D0 (en) Crystalline forms of bexagliflozin, processes for the preparation and use thereof
GB202011431D0 (en) Polymorphs of vadadustat and methods for preparing the polymorphs
PT3969459T (en) Process and intermediates for the preparation of eldecalcitol
HUP2100077A1 (en) Process for the preparation of avapritinib and intermediates for the process
IL314924A (en) Processes for the preparation of phenyltetrahydrofuran compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)